| CAS: | 66357-59-3 | |||||
| 分子式: | C13H23ClN4O3S | |||||
| 分子量: | 350.86 | |||||
| 熔点: | 133-134 °C | |||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| R838252 | MACKLIN | 盐酸雷尼替丁 | 98%,solid | 50元/1g; 125元/5g; 375元/25g; 1280元/100g; 3747元/500g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:2-8°C 状态:灰白色到浅黄色粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| R795611 | MACKLIN | 盐酸雷尼替丁 | 10mM in DMSO | 820元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| R0073 | TCI | Ranitidine Hydrochloride | >98.0%(T)(HPLC) | 465元/5G; 1090元/25G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 200704 | J&K | Ranitidine Hydrochloride | 98%, 一种组胺H2-受体拮抗剂, IC50为3.3 μM | 266元/5G; 941元/25G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Ranitidine是组胺H2-受体拮抗剂,IC50为3.3±1.4 μM。 靶点(IC50 & Targe) H2 receptor 体外研究 Ranitidine使肝细胞从激活的中性粒细胞的毒性产物 被杀死,而Famotidine缺乏这种能力。[1] Ranitidine抑制脂多糖体外刺激的单核细胞产生肿瘤坏死因子-α(TNF-α)。[2] 在分离的豚鼠肝细胞中,Ranitidine剂量依赖性地减少吗啡Kel,最大效应为50%,并增加吗啡-6-葡糖苷酸和吗啡-3-葡糖苷酸的相对浓度。Ranitidine逐渐减小吗啡-3-葡糖苷酸/吗啡-6-葡糖苷酸比高达21%。[3] 体内研究 在大鼠中,Ranitidine导致肝损伤,证据是6小时内增加的血清丙氨酸转氨酶,天冬氨酸转氨酶和γ-谷氨酰转移酶活性。[1] 在大鼠中,Ranitidine导致肝损伤,证据是6小时内增加的血清丙氨酸转氨酶,天冬氨酸转氨酶和γ-谷氨酰转移酶活性。[2] 在LPS/ RAN处理的大鼠中,Ranitidine在肝损伤之前增强LPS诱导的凝固,以及抗凝血剂减少肝损伤。在肝血窦的形成过程中,Ranitidine/LPS处理导致大鼠纤维蛋白凝块,并预防与减少的肝细胞损伤相关的纤维蛋白沉积。在大鼠中,Ranitidine在肝细胞损伤前增强LPS诱导的TNF的增加。[4] 在大鼠中,Ranitidine在高架十字迷宫中表现抗焦虑作用,表现在更多的时间留在开放臂上,更多的最终偏移。[5] 参考文献 [1] Luyendyk JP, et al. J Pharmacol Exp Ther,?003, 307(1), 9-16. [2] Okajima K, et al. J Pharmacol Exp Ther,?002, 301(3), 1157-1165. [3] Aasmundstad TA, et al. Pharmacol Toxicol, 1998, 82(6), 272-279. [4] Tukov FF, et al. Toxicol Sci,?007, 100(1), 267-280. [5] Privou C, et al. Neuropharmacology,?998, 37(8), 1019-1032. 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| B22260 | Alfa Aesar | Ranitidine Hydrochloride | 99% | 630元/5g; 2328元/25g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
应用 备注 基本信息 MDL EINECS 分子式 分子量 熔点 灵敏度 形态 溶解性 Merck GHS危害和防范说明 Hazard Statements 安全信息 TSCA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| R101 | Sigma-Aldrich | Ranitidine Hydrochloride | solid | 453.64元/1 G; 1112.6元/5 G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 应用 盐酸雷尼替丁已被用作开发和验证平行人工膜渗透性试验 (PAMPA) 的参考化合物。 包装 1, 5 g in poly bottle 生化/生理作用 雷尼替丁主要用于治疗非甾体类抗炎药 (NSAID) 引起的胃肠道损害。 特点和优势 该化合物由GlaxoSmithKline开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| R0150000 | Ranitidine Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 H2 组胺受体拮抗剂;抗溃疡剂。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR1026 | Supelco | Ranitidine Hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Material | 1025.53元/500 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Ranitidine hydrochloride is a H2-receptor antagonist, widely used for the management of hypersecretory conditions and for the treatment of duodenal ulcer. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. 生化/生理作用 H2 histamine receptor antagonist; anti-ulcer agent. 分析说明 These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAA5630 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0001787 | Ranitidine for impurity A identification | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 生化/生理作用 H2 组胺受体拮抗剂;抗溃疡剂。 包装 Unit quantity: 15mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1598405 | USP | Ranitidine Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 H2 组胺受体拮抗剂;抗溃疡剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BP471 | Ranitidine Hydrochloride | British Pharmacopoeia (BP) Reference Standard | 1952.55元/100 MG; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 H2 组胺受体拮抗剂;抗溃疡剂。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 243895 | Fluorochem | Noctone | 95% | 220元/500mg; 924元/5g; 2178元/25g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||